All Type of News
KFDA to rate pharmaceutical company by drug adverse reports.
In an attempt to activate the drug adverse report activities at all concerned authorities, the KFDA announced on April 25 that the relevant health agencies should collect drug adverse reaction reports on quarterly bas...
KPA's official statement on manipulated bio equivalency tests.
The Korea Pharmaceutical Association (KPA) announced an official statement on April 26 over the late KFDA's case report of the bio equivalency test fraud covering that the unfortunate incidence should make a critical ...
KFDA needs enough officers for bio equivalency test administration
Rep. Moon Hee of the opposition Grand National Party said that the KFDA had only 7 responsible officers for the drug bio equivalency test and the test review took roughly 2
months, indicating a need of more manpower...
KFDA no excluded drug makers on test manipulation scandal.
The KFDA reported 4 test institutes related with the fraudulent bio equivalency test such as Lab Frontier, KPTA Bio Test Center, Bio Core and Sunkyunkwang Univ. to the public prosecutor but did not decide a similar pr...
Civic group blames MOHW/KFDA for manipulated test scandals.
The Health Right Network, a civic group for the people's health, released an official statement on April 26 against the bio equivalency test manipulation scandal, saying that the bio equivalency test manipulation inci...
Industry says "we are a victim" of bio equivalency test scandal.
The pharmaceutical industry tried hard to minimize any possible adverse consequences to the fraudulent bio equivalency test scandal while expressing a harsh backlash in behind as saying "We are an inadvertant victim"....
Bio equivalency test scandal no affected to drug wholesalers.
10 drug companies had admitted the KFDA's investigation report on the bio equivalency test manipulation, which raised an overall catastrophic consequence to all drug industries, However, it did not give a serious impa...
Sharp rising oil price speeds up joint logistic service project.
Rising oil prices, a sign of entering the age of high oil price, has pressed for even drug wholesalers to concern sensitively about their logistic expenses.
The wholesale community said on April 25 that daily 2 to ...
No NHI reimbursable for 10 drugs of bio equivalency test scandals.
The MOHW said that 10 drugs complicated with the bio equivalency test manipulation would be deleted from the NHI reimbursement schedule taking effects from April 25.
10 drugs include Fosanex 70mg tab., Kolon Alrend...
LG to get European health regulatory approval of Beltropin.
LG Life Science announced on April 26 that the registration of Human Growth Hormone (A day dosage form) was completed by BioPartners, an associate company of LG.
LG Life Science and BioPartners applied the registr...
